All Asthma articles
-
InformationGINA ASTHMA STRATEGY 2020
Asthma affects an estimated 300 million individuals worldwide, and still imposes an unacceptable burden on healthcare systems, society through loss of productivity in the workplace, and, especially for paediatric asthma, disruption to the family. Asthma affects all age groups and contributes to many deaths worldwide. The Global Initiative for ...
-
Working party guideline/algorithm
Inhaler choice guideline
Information is intended for healthcare professionals only. This management algorithm was developed by MGP Ltd and supported by Chiesi Ltd through the provision of a grant for its production. Chiesi Ltd had no editorial control other than to check factual accuracy. See end of algorithm for ...
-
Independent professional body guideline
GINA strategy 2020: assessing patients with asthma
This Guidelines summary outlines recommendations for assessing patients with asthma. Please refer to the full report for the complete set of recommendations.
-
Independent professional body guideline
GINA strategy 2020: asthma–COPD overlap
This Guidelines summary outlines recommendations for the diagnosis and initial treatment of adults with features of asthma, chronic obstructive pulmonary disease (COPD), or both.
-
Independent professional body guideline
GINA strategy 2020: management of asthma
This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged six to 11.
-
Independent professional body guideline
GINA strategy 2020: diagnosis of asthma
This Guidelines summary outlines recommendations for making the diagnosis of asthma in adults and children over five years of age. Please refer to the full report for the complete set of recommendations.
-
Prescribing summary card
DuoResp® Spiromax® (budesonide/formoterol)
Information intended for healthcare professionals only. This prescribing summary card was developed from content provided by Teva UK Limited in a format developed by Guidelines . Teva UK Limited commissioned the development of the prescribing card and carried out full medical approval to ensure compliance with regulations. ...
-
Video
Dr Kevin Gruffydd–Jones Q&A on asthma
In this video, taken at Guidelines Live 2019, Dr Kevin Gruffydd–Jones answers questions on recent asthma guidelines updates, significant differences between the guideline updates, what is on the horizon for asthma guidelines, and his key take-home messages.
-
Video
Dr Mark Levy Q&A on difficult-to-treat and severe asthma
In this video, taken at Guidelines Live 2019, Dr Mark Levy answers questions on difficult-to-treat and severe asthma, the guidance that is available, and his key take-home messages
-
NICE guideline
NICE asthma guideline: diagnosis and monitoring
A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms.
-
NICE guideline
NICE asthma guideline: chronic asthma management
A practical summary of NICE recommendations on managing chronic asthma in children, young people, and adults, including three management algorithms.
-
Supplement
The re-usable Respimat® Soft Mist™ inhaler
Information for healthcare professionals only. This supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines for Nurses . Please see bottom of page for full disclaimer. View prescribing information Download the supplement Foreword Jane Scullion, ...
-
Supplement
The re-usable Respimat® Soft Mist™ inhaler
Information for healthcare professionals only. This supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines . Please see bottom of page for full disclaimer. View prescribing information Download the supplement The re-usable Respimat ® Soft ...
-
Supplement
Asthma guidance update
This Guidelines supplement has been commissioned and funded by Mylan and developed in partnership with Guidelines . The content on page 3 was commissioned by Mylan and Mylan has carried out full medical review and approval to ensure compliance. See page 2 for full disclaimer. Prescribing information can ...
-
Independent professional body guideline
SIGN and BTS management of asthma in adults guideline
A concise summary of the 2019 BTS/SIGN guidance on the management of asthma in adults. Features a diagnosis and pharmacological management algorithm.
-
Independent professional body guideline
SIGN and BTS management of asthma in children guideline
A concise summary of the 2019 BTS/SIGN guidance on the management of asthma in children. Features a diagnosis and pharmacological management algorithm.
-
Feature article
Spirometry—it’s meaningless if incorrect!
With 15 years of expertise in spirometry, Chris Loveridge answers your questions about spirometry and emphasises the need to take a clinical history.
-
Feature article
Device selection in children and adults
Jane Scullion provides some simple and practical advice on optimal inhaler device selection for adults and children.
-
Feature article
Striking a balance: device choice and therapeutic dosages
Jane Scullion looks at the increasing complexity of the multitude of MDI and DPI devices that are available and the therapeutic options they offer.
-
Test and reflect
NICE guideline on chronic asthma management
This CPD activity consists of 8 multiple-choice questions (MCQs) designed to test your knowledge on the management of chronic asthma—you will then be prompted to reflect on your learning.
